Search results
Comparison of Haemodynamic Responses to Landiolol Versus Esmolol
Author(s):
Georgios Koukoulitsios
,
Kyriaki Tsikritsaki
,
Georgios Magklaras
,
et al
Added:
1 year ago
Original Research
SGLT-2 Inhibitors and Heart Failure
Author(s):
C Noah Nilsson
,
Mads Kristian Ersbøll
,
Finn Gustafsson
Added:
1 year ago
Review Article
Author(s):
Jasper J Brugts
Added:
2 years ago
HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation,…
View more
Author(s):
Marat Fudim
Added:
2 weeks ago
Dr Marat Fudim (Duke University School of Medicine, Durham, NC, US) joins us to discuss congestion phenotypes in heart failure, the distinction between true volume overload and maladaptive volume redistribution, and the emerging role of greater splanchnic nerve modulation.In this interview, Dr Fudim explores one of the most clinically nuanced challenges in heart failure management:…
View more
Dan Burkhoff
Research Area(s) / Expertise:
Author
Expertise
MI/ACSSTEMIHeart FailureInterventionCoronary InterventionsCoronary Artery DiseaseAcute and Advanced Heart FailureBifurcationHeart Failure Services, Prevention and Digital HealthTransradial InterventionMedication Optimisation and TitrationCoronary PhysiologyIntravascular ImagingPrevention & Chronic Conditions
Thomas Weber
Job title: Associate Professor
Author
José M de la Torre Hernández
Job title: Head of Hemodynamics and Interventional Cardiology
Author
Author(s):
Added:
7 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview…
View more
Ilaria Battistoni
Research Area(s) / Expertise:
Author
Expertise
MI/ACSSTEMIHeart FailureInterventionCoronary InterventionsCoronary Artery DiseaseAcute and Advanced Heart FailureBifurcationHeart Failure Services, Prevention and Digital HealthTransradial InterventionMedication Optimisation and TitrationCoronary PhysiologyIntravascular ImagingPrevention & Chronic Conditions
Patricia Campbell
Research Area(s) / Expertise:
Author
Expertise
MI/ACSSTEMIHeart FailureInterventionCoronary InterventionsCoronary Artery DiseaseAcute and Advanced Heart FailureBifurcationHeart Failure Services, Prevention and Digital HealthTransradial InterventionMedication Optimisation and TitrationCoronary PhysiologyIntravascular ImagingPrevention & Chronic Conditions
